[The assessment of the efficacy of introducing a new method for treating gonorrhea].
Proteolytic enzymes (chymotrypsin, trypsin) i.m. injections in a dose of 5 mg twice daily for 4 to 10 days were used in combined therapy of 218 patients with recurrences of gonorrhea, gonorrheal epididymitis and orchiepididymitis; 23 patients with acute orchiepididymitis were injected heparin intramuscularly in a dose of 5000 U twice daily for 7 weeks. Etiologic cure was achieved in 99.7 percent, postgonorrheal residual phenomena were detected in 5.7 percent of cases (93.9 and 17.5 percent, respectively, in a reference group). The length of treatment of a patient with gonorrhea relapse shortened by 8.6 days on an average and of that with orchiepididymitis and epididymitis by 5.9 days. Formula are presented for calculating the economic efficacy of treatment of those working and not working patients.
Glozman
V N
VN
D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D003362:Cost-Benefit Analysis / Q000191:economics; D004359:Drug Therapy, Combination; D004823:Epididymitis / Q000188:drug therapy / Q000191:economics; D006069:Gonorrhea / Q000188:drug therapy* / Q000191:economics; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D008297:Male; D009920:Orchitis / Q000188:drug therapy / Q000191:economics; D010447:Peptide Hydrolases / Q000008:administration & dosage; D012008:Recurrence; D014586:USSR
D000900:Anti-Bacterial Agents; D006493:Heparin; D010447:Peptide Hydrolases
Ob otsenke éffektivnosti vnedreniia novogo metoda lecheniia gonorei.